Tuesday, September 19, 2017

Can Botox make you happy?

YouTube Lecture to Las Vegas Cosmetic Surgery Conference 2014 by Dr. Patrick Treacy regarding the effect of Botox on emotions, including both happiness and…

Wednesday, August 2, 2017

Campaign for Safe Cosmetics

Kids aren’t just “little adults.” Children are especially vulnerable to the effects of chemicals, and preventing early-life exposures to harmful chemicals can help prevent health problems throughout their lives. 
Despite these concerns, children’s cosmetic products — like the ones we tested — contain carcinogens and hormone disrupting chemicals. Tell Congress: Cancer-Chemicals & Heavy Metals Don’t Belong in Kid’s Face Paint or Makeup! 


Friday, July 7, 2017

Neauvia in the Prime Journal

Talking deeply about Neauvia wide range of fillers in the latest issue of Prime Journal, the International journal of Aesthetic and Anti-Ageing medicine.

Application Skin lifting, firmness, and elasticity NEAUVIA ORGANIC range of fillers is crosslinked with PEG, an outstanding new technology able to give the products a high safety and tolerability profile. Each reference of the filler line has a specific rheology, due to the particular chemical geometry and the real polymeric technology, to be effective and perfectly integrated in different anatomical planes. The high viscoelasticity and cohesivity of Neauvia INTENSE LINE promote an important tissue bio-integration of the medium and deep planes together with a high lifting power and a long-lasting effect.

 The polymeric 3D architecture containing CaHA of Neauvia STIMULATE LINE shows a scaffold-like action promoting a slow release of the microparticles, with a size of 10–12 microns, blocked in the hydrogel clusters, thereby activating the fibroblastic components at the metabolic level. The range is completed with a CaHA suspension in a linear hyaluronic acid filler with high viscosity for superficial correction and stimulation: the HYDRODELUXE LINE. 

Contact Neauvia ● www.neauvia.com

Friday, June 30, 2017

Facial Rejuvenation May Involve More ...

Facial Rejuvenation May Involve More Than Skin Tightening

Facial Rejuvenation May Involve More Than Skin Tightening | eReport | Plastic Surgery Practice

Most people worry about developing wrinkles and want to delay the effects of aging as much as possible to ensure they look their best. However, a new study published in the Journal of Experimental Social Psychology may prove there are more drawbacks to having wrinkles than just the aesthetics.

Wednesday, June 28, 2017

Botulinum Toxin Injections Between the Brows Produce Significant Patient Satisfaction Rates

Botulinum toxin type A injections are the most common cosmetic procedure performed in the United States. There were 4.3 million procedures performed in 2015 accounting for 42 percent of all cosmetic procedures in that year, based on the Cosmetic Surgery National Data Bank Statistics from the American Society for Aesthetic Plastic Surgery, (ASAPS). According to a 2016 study published in the Aesthetic Surgery Journal, the official publication of ASAPS, patient satisfaction with their overall facial appearance increased by 28 percent with injections to the so-called “11s” (the glabellar rhytids, which are the lines that appear between the brows as we age).
The satisfaction rate was determined based on participating patients’ completion of the FACE-Q survey, a newly developed and validated patient-reported outcome instrument that can be used for measuring a patient’s own perceptions of cosmetic facial procedures. The survey consists of 63 questions asking patients to evaluate their overall appearance, age appearance, and the appearance of cheeks, nasolabial folds, lower face and jawline, chin and neck.
Dr. Daniel C. Mills, president of ASAPS states, “The results of this study are not surprising and validate what we’ve suspected for quite some time. I see an ever-increasing influx of patients in my practice in Laguna Beach, California requesting botulinum toxin type A injections to the area between the brows and other areas on the face, like the crow’s feet and forehead as a preventative anti-aging or pre-aging measure from patients in their 20s up to their 70s. It’s a quick nonsurgical fix that packs a powerful punch. This new study reaffirms the efficacy of botulinum toxin type A and the satisfaction it brings to patients.”
The study’s authors examined 57 female patients who completed the FACE-Q survey. After the baseline survey, the patients received injections of one brand of botulinum toxin type A, (Botox, Dysport or Xeomin) in the region between the brows. Two weeks post-injection, the patients completed the FACE-Q survey again. The percentage changes in patient responses from the first to second surveys were assessed to determine how the injections affected patient satisfaction with their facial appearance.
Patients stated that they believe they look an average of 5.6 years younger post-injection with any of the botulinum toxin type A products. The average age of the 57 patients with pre- and post-neurotoxin FACE-Q responses was 49.6 years (range of 32-75 years old).
“This indicates that patients’ satisfaction with their overall facial appearance was statistically significantly greater after receiving the injections, and certainly accounts for the continued success of neurotoxin popularity to reduce the signs of aging,” states Dr. Ivona Percec, the study’s senior author.
To view the complete study, visit the Aesthetic Surgery Journal website, academic.oup.com/asj.
The American Society for Aesthetic Plastic Surgery (ASAPS), is recognized as the world’s leading organization devoted entirely to aesthetic plastic surgery and cosmetic medicine of the face and body. ASAPS is comprised of more than 2,600 plastic surgeons; active members are certified by the American Board of Plastic Surgery (USA) or by the Royal College of Physicians and Surgeons of Canada and have extensive training in the complete spectrum of surgical and nonsurgical aesthetic procedures. International active members are certified by equivalent boards of their respective countries. All members worldwide adhere to a strict code of ethics and must meet stringent membership requirements.
Courtesy of The American Society for Aesthetic Plastic Surgery

Thursday, June 8, 2017

More isn't always better: making better health-care choices

More isn't always better: making better health-care choices
Canadians have more than one million unnecessary medical tests, treatments and procedures every year. But we can improve patient outcomes and save resources

By Wendy Levinson
Expert Adviser
Wendy Levinson
Click image for Hi-Res
TORONTO, Ont./Troy Media/ - Each year, at least one million unnecessary tests, treatments and procedures are done in Canadian health-care settings. This means that hundreds of thousands of Canadians are exposed to potential harm by unnecessary care.
Unnecessary care could be a prescription drug, a diagnostic test or a medical procedure that doesn't improve a patient's health outcomes and isn't backed by the best available evidence. It may also involve risks and harmful side-effects.
In other words, this medical care offers no value to patients and strains resources.
A recent report from the Canadian Institute for Health Information (CIHI), in partnership with Choosing Wisely Canada, demonstrates how pervasive unnecessary care is across the country and highlights several key examples where changes could benefit patients and the health system.
So what are we better off without?
Unnecessary imaging has consequences.
The report says about 30 per cent of patients visiting Ontario and Alberta emergency departments for minor head injuries have CT scans. CT scans deliver strong X-ray radiation. Exposure to this radiation can increase lifetime cancer risk. Yet evidence shows there are good alternatives to CT scans for investigating head injuries. For example, doctors can use a set of questions, known as a clinical decision rule, to assess the severity of a head injury and decide if further diagnostic testing is warranted.
Unnecessary medications have side-effects.
The report estimates that one in 10 Canadian seniors regularly uses sleeping pills, known as benzodiazepines, and other sedative hypnotics. The long-term use of these medications outweighs benefits, which is why they're only recommended for short-term use. These medications increase the risk of falls causing injuries and car accidents in seniors.
Seniors aren't the only population where there is unnecessary and potentially harmful medication use. The report shows a disturbing 300 per cent increase in dispensed prescriptions for the powerful antipsychotic quetiapine for insomnia in children and youth in Manitoba, Saskatchewan and British Columbia. This drug is not recommended for children or youth and has a long list of harmful side-effects.
An important finding of the report is wide variation across regions and between provinces. Variation means major differences in medical practice, some of which are not evidence-based and can be harmful to patients.
Reducing variation improves quality for all Canadian patients and can reduce waste. A good example is pre-operative testing. In Ontario, nearly one in three patients having eye surgery had a preoperative test, compared to one in five in Alberta.
Medicine has evolved and so has medical practice. It used to be standard that before certain surgeries, like hip or knee replacements or cataract surgery, pre-operative tests would be done to ensure a patient was fit for surgery. These tests could include blood work, electrocardiograms and chest X-rays. As surgical techniques and technology evolve, however, most of these pre-operative tests are no longer needed unless there's a specific concern.
In spite of the pervasiveness of unnecessary care, the picture isn't bleak. The report also provides several examples of how health-care providers work hard to put in place better practices or protocols to reduce waste, which may also harm patients.
We know patients are aware of this problem, too. Ipsos Reid survey data shows that one in four Canadians say they have experienced unnecessary care in the past year. And 67 per cent of Canadians surveyed believe patient demand is also responsible for unnecessary care, rather than decisions made by health-care providers alone. Nearly half (42 per cent) of Canadians surveyed said they expect a test ordered or a prescription written when they visit a doctor's office.
But the vast majority (92 per cent) of Canadians surveyed also said they need more information to help make decisions and ask the right care questions.
So what should patients do?
Choosing Wisely Canada, a national, clinician-led campaign, has four key questions a patient can ask their care provider to help start a conversation about unnecessary care:
  • Do I really need this test, treatment or procedure?
  • What are the downsides?
  • Are there simpler, safer options?
  • What happens if I do nothing?
Together with health-care providers, Canadians can help reduce unnecessary care by asking questions and having conversations about when more isn't always better.
Wendy Levinson, MD, OC, is an expert adviser with EvidenceNetwork.ca, the chair of Choosing Wisely Canada and a professor of medicine at the University of Toronto.
© 2017 Distributed by Troy Media

Friday, June 2, 2017


Injectable medical devices are products that are in direct contact with the patient’s skin and mucosa for extended periods of time.
The complete absence of systemic and, first and foremost, direct cellular toxicity is the essential requirement for a filler that is implanted in the skin and remains there for 8 months (on average).
For this reason in particular, in order to exclude even the lowest of cytotoxic effects, increasingly sensitive cytotoxicity assays are needed - which means performing in vitro tests using immortalised human keratinocytes as cell line.
Cytotoxicity can be assessed with the MTT test, which relies on mitochondrial activity. The test, originally developed by Mosman in 1983, is simple, accurate and yields reproducible results (Mosman, 1983). The MTT test is based on the principle that, in most viable cells, mitochondrial activity is constant, so an increase or decrease in the number of cells is directly proportional to mitochondrial activity. Viable cells convert MTT tetrazolium salts into formazan crystals, which can be solubilised in dimethyl sulphoxide (DMSO) for homogeneous spectrophotometric measurement. Therefore any change in the number of viable cells can be detected by measuring the optical density of formazan at 570 nm.
NEAUVIA STIMULATE Hydrogel 26 mg of HA with 1 % hydroxyapatite has shown complete absence of cytotoxicity at various concentrations, even ones higher than the normal concentration used for clinical purposes.
NEAUVIA STIMULATE is a "hybrid" filler, new, safe and reversible, which concentrates in a single product both the tissue filling functions of a filler and the collagen production of particle fillers, which already have successfully been on the market for years. The amount of collagen produced by NEAUVIA STIMULATE is comparable to particle fillers, without having the problem of being irreversibile. NEAUVIA STIMULATE is recommended for interventions on hands, cheeks, nasoslabial and jaw area, and the aesthetic corrections last approximately 12 months.
Prime Journal

Tuesday, May 30, 2017

Neauvia developed a unique MAN LINE of bioactive fillers and mesotherapy products..

Being aware of the differences between men and women tissue as well as their subjective expectation from the aesthetic medicine, Neauvia developed a unique MAN LINE of bioactive fillers and mesotherapy products.


Friday, May 26, 2017

Neuromuscular Toxins

The first option, which is most appropriate for active lines or age associated wrinkles that are just starting to appear, is to temporarily weaken or paralyze the muscle that is causing the wrinkle. Botulinum Toxin type A is a family of neurotoxins that block nerve signals that cause muscles to contract.

The toxin works directly where it is placed, and thus can be artistically used to alter facial expressions. Botox Cosmetic® is widely recognized, and was the first neurotoxin to be approved for cosmetic use in the United States. Other manufactures are producing variant toxins that will likely be approved for use in the near future, including Reloxin and PurTox. These toxins will be differentiated by their time to onset, duration of effect (the clinical effects of Botox Cosmetic® are typically 3 to 4 months), and the distance of effect from the injection site.

 Risks include bruising at the injection site, rare chance of an infection, and the possibility of unintentionally affecting nearby muscle groups. Specific risks should be discussed with your injector when considering treatment.

Friday, May 12, 2017

Wednesday, May 10, 2017

How is Dermal Filler Different to Botox?

 by Dr Timothy Beazleigh

How is Dermal Filler Different to Botox?

People are often confused by the difference between Botox and dermal filler treatments, assuming they are the same. Whilst Botox is a muscle relaxant and is used to minimise muscle contraction thus reducing fine lines and wrinkles on facial movement, dermal filler is used specifically to restore volume to deeper, lines, creases and folds that are usually static i.e. permanently visible on the face even when the face isn’t moving.

Traditional areas to treat with standard dermal fillers – including Juvederm and Restylane – are the nasolabial folds (corner of the nostrils to corners of the mouth), marionette lines (corners of mouth to chin/jowls) and the smokers lines (above the top lip). Thicker, more volumising fillers including Juvederm Voluma are used specifically to the mid face region to augment cheek bones, restore volume and plumpness to the lower cheeks and redefine the chin and temples. Fillers are also used to enchance and recontour lips.

As a treatment with dermal fillers requires the needle to penetrate the dermis deeper than for a standard Botox treatment, there is usually more opportunity for bruising to occur as the blood vessels are not visible to the practitioner (beyond the superficial layer), but bruising is by no means a standard side effect and occurs in approximately 50% of treatments.

Juvederm is the filler of choice at Melior Clinics Botox & Facial Aesthetic London Clinic as, being monophasic, it is smooth in consistency and also contains a built in anaesthetic, making the process a lot more comfortable for the patient.

Wednesday, May 3, 2017

Laser treatment for permanent filler complications

Employing an intralesional laser to treat inflammatory complications caused by permanent facial fillers showed a 92% overall improvement rate, according to an Italian study that appeared in the August issue of Plastic and Reconstructive Surgery.
A total of 218 consecutive patients (204 of whom were women) with a mean age of 49 years were treated with an 808 nm diode laser (LASEmaR 800; Eufoton, Treiste, Italy) between 2006 and 2013.
Patients with infiltrating distribution in the tissues, as in crisscross retrograde injection, were managed by intralesional laser treatment alone. However, patients with cystic distribution in the tissues, as in bolus injections, were treated with both laser-assisted evacuation and drainage through stab wound incisions.
Researchers chose the 810 nm wavelength because of less associated pain than other infrared diodes.
Typically, no anesthesia is required for the laser treatment, according to the study authors, which consists of percutaneously inserting a 200-micron fiberoptic laser directly into the lesions and drilling several small holes. The result is removal of the foreign substance and the inflammatory reaction.  
“A period of up to 6 months is usually necessary to fully appreciate the resolution of the lump together with the healing of the surrounding inflammation often extended far beyond the original implant,” writes lead author Daniel Cassuto, M.D., and his associates from Modena and Milan, Italy.

Tuesday, May 2, 2017

Product Review: Neckline Slimmer


by Luke Willson

Product Review: Neckline Slimmer
For anyone struggling with "turkey neck" or a double chin, the Neckline Slimmer sounds almost too good to be true. Two minutes a day of moving your chin up and down against something with a little spring in it? Well, that sounds easy enough. Thanks to the Neckline Slimmer's inventor Paul Younane, an ex-professional rugby player turned physiotherapist, this new, "as-seen-on-TV" fad may actually be the solution to a problem many of us have to deal with. Or is it?
The Neckline Slimmer is a portable, affordable, easily operated device, small enough to fit in a purse. To use it, one end is placed on the chest, while a moveable pad rests under the chin. A spring contained within provides resistance (different springs are provided to adjust the level of intensity). By repeatedly depressing the pad, like a bicycle pump, in a nodding motion, the claim is that noticeable tightening along the jowls will be acheived in as little as two weeks.
Younane's product works on this simple principle: prolonged resistance exercise with a muscle group reduces surrounding deposits of fat. Consequently, the skin around the area will acquire a tighter appearance. While the Neckline Slimmer is designed to target the muscles on the front and side of the neck, this principle applies to all muscle groups. The key is that persistence over time is essential - like any exercise, the results only become noticeable gradually.
As we age, our skin sags, and the neckline is often the first area to go. However, diet and exercise aren't always enough to counteract the natural process of aging. It's enough to drive one to frustration. A product like the Neckline Slimmer certainly offers the opportunity for its user to regain more youthful contours over time. Keep in mind, however, this treatment system strengthens muscle and reduces fat deposits. If you are experiencing excessive amounts of loose, sagging skin on the neck and jaw, it might not be the right option for you. Real results may require an actual cosmetic procedure, such as a neck lift.
Neck Lift is a relatively simple cosmetic surgical procedure, like a mini-facelift for your neck, whereby loose, sagging skin is lifted and repositioned, giving you more toned, youthful definition. In fact, the Neck Lift can even be combined with a Facelift for even greater results. Or, if excessive fat is what you're looking to reduce, some minor liposuction under the chin might also be an option. A local plastic surgeon can help you decide what type of approach can deliver your desired in the simplest, safest, and quickest manner possible.
If cosmetic surgery sounds too serious, perhaps a less-invasive neckline treatment would interest you. Refirme®, which uses targeted heat energy to tighten skin, smooth out wrinkles and balance skin tone, will not only help give your neck better definition, it can even out your skin tone for an all-over luminous glow. Lipodissolve, a popular new injectable for breaking down fat deposits, is also a great non-surgical solution for slimming the neckline.
Everyone's body reacts differently to cosmetic procedures, and your specific characteristics will determine how a treatment affects you. Only a face-to-face consultation with a medical professional can give you the necessary information about your specific needs. If you'd like to learn more about any of the procedures mentioned or find a local provider, feel free to click here, or call 888.517.4187. And if you're interested in the Neckline Slimmer but would rather not buy an As Seen on Tv product, a nerf ball placed under the chin could very well offer the same type of resistance exercise!